标题
Novel antibiotics: Are we still in the pre–post-antibiotic era?
作者
关键词
Tedizolid, Ceftolozane, Omadacycline, Avibactam, Cadazolid
出版物
INFECTION
Volume 43, Issue 2, Pages 145-151
出版商
Springer Nature
发表日期
2015-02-20
DOI
10.1007/s15010-015-0749-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- New antimicrobial approaches to gram positive respiratory infections
- (2015) Adamantia Liapikou et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
- (2014) Françoise Van Bambeke ANNALS OF MEDICINE
- Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections
- (2014) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- (2014) Andrew F. Shorr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
- (2014) Wafi Siala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)
- (2014) Robert K. Flamm et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections
- (2014) Emilio Maseda et al. Expert Review of Anti-Infective Therapy
- In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: Comparison with ceftazidime, piperacillin/tazobactam and imipenem
- (2014) Cédric Bretonnière et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)
- (2014) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12)
- (2014) Helio S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
- (2014) Gregory J Moran et al. LANCET INFECTIOUS DISEASES
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance
- (2014) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
- (2014) Shawn Flanagan et al. PHARMACOTHERAPY
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftaroline-Avibactam Tested against Clinical Isolates Collected from U.S. Medical Centers in 2010-2011
- (2013) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
- (2013) David Oldach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis
- (2013) C. Lübbert et al. INFECTION
- Activity of BAL30072 alone or combined with -lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters
- (2013) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses
- (2013) D. Baldoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection
- (2013) C. H. Chilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in anIn VitroPharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureus Infection
- (2012) Adam Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
- (2012) A. Dalhoff INFECTION
- In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
- (2012) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
- (2011) Lala M. Dunbar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of BAL30072 against Burkholderia pseudomallei
- (2011) Takehiko Mima et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now